Psi Advisors, LLC Gilead Sciences, Inc. Transaction History

Psi Advisors, LLC

$338 Million
Q3 2024

A detailed history of Psi Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Psi Advisors, LLC holds 568 shares of GILD stock, worth $51,227. This represents 0.01% of its overall portfolio holdings.

Number of Shares

568

Previous 968 41.32%

Holding current value

$51,227

Previous $66,000 28.79%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$66.59 - $83.99 $26,636 - $33,596	-400 Reduced 41.32%	568 $47,000
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $11,682 - $13,482	185 Added 23.63%	968 $66,000
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $5,726 - $6,983	-80 Reduced 9.27%	783 $57,000
Q2 2023 Jul 21, 2023	SELL	$76.01 - $86.7 $304 - $346	-4 Reduced 0.46%	863 $66,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $50,251 - $57,252	-650 Reduced 42.85%	867 $71,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $515,386 - $739,916	-8,270 Reduced 84.5%	1,517 $0
Q3 2022 Oct 20, 2022	SELL	$59.54 - $68.01 $66,982 - $76,511	-1,125 Reduced 10.31%	9,787 $603,000
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $26,839 - $30,229	465 Added 4.45%	10,912 $674,000
Q1 2022 Apr 20, 2022	SELL	$57.92 - $72.58 $15,522 - $19,451	-268 Reduced 2.5%	10,447 $621,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $14,468 - $16,421	223 Added 2.13%	10,715 $778,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $16,719 - $18,038	247 Added 2.41%	10,492 $733,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $11,424 - $12,482	180 Added 1.79%	10,245 $705,000
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $45,000 - $51,344	750 Added 8.05%	10,065 $650,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $47,132 - $53,705	-832 Reduced 8.2%	9,315 $542,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $240,327 - $302,169	3,870 Added 61.65%	10,147 $641,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $246,534 - $286,272	-3,408 Reduced 35.19%	6,277 $482,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $161,272 - $206,566	2,575 Added 36.22%	9,685 $724,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $438,118 - $481,915	7,110 New	7,110 $462,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.

Account